Publicaciones en colaboración con investigadores/as de McMaster University (3)

2023

  1. Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients with Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)

    Journal of Clinical Oncology, Vol. 41, Núm. 1, pp. 43-53

  2. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615

2014

  1. Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial

    The Lancet Oncology, Vol. 15, Núm. 11, pp. 1263-1268